BOSTON THERAPEUTIC USD0.001 (BTHE)

0.14
0.01 12.00
OTC
Prev Close 0.12
Open 0.16
Day Low/High 0.13 / 0.16
52 Wk Low/High 0.03 / 0.23
Volume 81.80K
Exchange OTC
Shares Outstanding 44.32B
Market Cap 5.54M
Div & Yield N.A. (N.A)

SeeThruEquity Issues Quarterly Update On Boston Therapeutics

SeeThruEquity, a leading New York City based independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has issued a quarterly update on Boston...

[video] New Tablet From Boston Therapeutics Reduces Sugar Intake for Diabetics

Boston Therapeutics new PAZ320 tablet is designed to reduce a person's sugar intake before eating a meal.

Boston Therapeutics' New Tablet Reduces Sugar Intake for Diabetics

Boston Therapeutics new PAZ320 tablet is designed to reduce a person's sugar intake before eating a meal.

Boston Therapeutics, Inc. Investor Presentation Now Available For On-demand Viewing At RetailInvestorConferences.com

Company invites individual and institutional investors to log-on to view presentation